# Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer

> **NCT07537361** · PHASE2 · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 108 (estimated)

## Conditions studied

- Gastric Cancer
- Leucine-restricted Diet

## Interventions

- **DIETARY_SUPPLEMENT:** Leucine-restricted diet

## Key facts

- **NCT ID:** NCT07537361
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537361, "Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07537361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*